Morten Frimann Hansen

Director, Global Capex at Bavarian Nordic

Morten Frimann Hansen has extensive work experience in project management and engineering roles within the pharmaceutical industry. Morten currently serves as a Senior Project Manager at Bavarian Nordic, a position they have held since March 2023. Prior to this, Morten worked at Applied Management Group ApS, where they held various roles including Senior Project Manager at NNE from November 2021 to February 2023, Senior Project Manager at LEO Pharma from June 2017 to October 2021, and Senior Consultant from October 2016 to June 2017.

Before joining Applied Management Group ApS, Morten worked at LEO Pharma A/S from 2008 to 2016. During their time at LEO Pharma, they served as a Manager from October 2013 to October 2016, where they had overall responsibility for planning and executing investment projects related to GMP processes, utilities, HVAC, electrical, buildings, and energy reductions. Morten also managed a team of 13 project managers and coordinated the project portfolio. Prior to that, Morten held the positions of Senior Project Manager from May 2013 to October 2013, Project Team Leader from April 2011 to April 2013, Senior Project Manager from July 2010 to April 2011, and Project Manager from October 2008 to July 2010.

Earlier in their career, Morten worked as a Project Engineer at Alectia from October 2007 to September 2008. Morten also worked at Novo Nordisk A/S as an Engineer from December 2000 to September 2007, where they were responsible for technical support and project management of utility projects. Morten began their career at Ferrosan A/S as an Engineer from March 1995 to December 2000.

Morten Frimann Hansen studied Mechanical Engineering at Copenhagen Technical College. The exact duration of their education is unknown.

Location

Copenhagen, Denmark

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Bavarian Nordic

8 followers

Bavarian Nordic A/S is a biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases.


Industries

Employees

501-1,000

Links